A Study to Evaluate the Safety and Efficacy of Elagolix for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women

NCT03886220 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

82

Enrollment

INDUSTRY

Sponsor class

Conditions

Uterine Fibroids

Interventions

DRUG: Elagolix
DRUG: Placebo

Sponsor

AbbVie